The Unintended Consequences Of The Swiss-EU Medtech MRA Failure
Manufacturers will have to adjust to new medtech labeling rules to enter the Swiss market, but how far will patients relying on imports of low-risk medical devices be affected when the Swiss-EU MRA transition period ends?
